HYTN Innovations Inc. (CNSX:HYTN) entered into purchase agreement to acquire Prism Scientific Labs Inc for CAD 4.7 million on June 13, 2024. The consideration consists of 12.1 million common equity of HYTN Innovations Inc. to be issued for common equity of Prism Scientific Labs Inc. The transaction includes Closing is subject to several standard closing conditions, including receipt of regulatory approvals.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.37 CAD | 0.00% | -9.76% | +428.57% |
06-27 | HYTN Awarded Drug Establishment License from Health Canada | MT |
06-27 | HYTN Innovations Inc. Receives Drug Establishment License from Health Canada, Expanding GMP Capabilities | CI |
1st Jan change | Capi. | |
---|---|---|
+428.57% | 20.9M | |
+8.45% | 275B | |
+2.40% | 46.25B | |
+31.74% | 25.53B | |
-2.11% | 16.77B | |
+5.54% | 13.41B | |
+17.48% | 12.51B | |
+22.73% | 11.23B | |
+4.39% | 11.17B | |
+15.35% | 10.04B |
- Stock Market
- Equities
- HYTN Stock
- News HYTN Innovations Inc.
- HYTN Innovations Inc. entered into purchase agreement to acquire Prism Scientific Labs Inc for CAD 4.7 million.